第一作者机构：[1]Capital Med Univ, Xuanwu Hosp, Dept Hematol, Beijing, Peoples R China
通讯作者：
通讯机构：[1]Capital Med Univ, Xuanwu Hosp, Dept Hematol, Beijing, Peoples R China
推荐引用方式(GB/T 7714)：
Guo Yixian,Lan Xiaoxi,Chang Xiaoli,et al.Ibrutinib in Combination with Rituximab and High-Dose Methotrexate in Newly Diagnosed Primary Central Nervous System Lymphoma Patients[J].BLOOD.2021,138:doi:10.1182/blood-2021-147742.
APA：
Guo, Yixian,Lan, Xiaoxi,Chang, Xiaoli,Wang, Guoxiang,Zou, Dongmei...&Sun, Wanling.(2021).Ibrutinib in Combination with Rituximab and High-Dose Methotrexate in Newly Diagnosed Primary Central Nervous System Lymphoma Patients.BLOOD,138,
MLA：
Guo, Yixian,et al."Ibrutinib in Combination with Rituximab and High-Dose Methotrexate in Newly Diagnosed Primary Central Nervous System Lymphoma Patients".BLOOD 138.(2021)
医学